Serodiagnosis and Immunotherapy in Infectious Disease最新文献

筛选
英文 中文
The value of ELISA vs. negative Coombs findings in the serodiagnosis of human brucellosis ELISA与阴性Coombs结果在人布鲁氏菌病血清诊断中的价值
Serodiagnosis and Immunotherapy in Infectious Disease Pub Date : 1997-01-01 DOI: 10.1016/S0888-0786(96)01073-6
G.F. Araj , G.N. Awar
{"title":"The value of ELISA vs. negative Coombs findings in the serodiagnosis of human brucellosis","authors":"G.F. Araj ,&nbsp;G.N. Awar","doi":"10.1016/S0888-0786(96)01073-6","DOIUrl":"10.1016/S0888-0786(96)01073-6","url":null,"abstract":"<div><p>This study was conducted to assess the value of ELISA findings in relation to negative findings in the <em>Brucella</em>-antihuman globulin (Coombs) test and in relation to the clinical condition of patients. One hundred and thirty three serum specimens, representing the same number of patients, submitted for serologic testing for brucellosis and showing negative Coombs, were tested by ELISA to determine their <em>Brucella</em>-IgG, -IgM and -IgA antibodies. Concordant negative results between Coombs and ELISA were found in 95 (71.4%) patients whose medical records also did not reveal suggestive clinical signs or symptoms of brucellosis. The elevated ELISA readings in the remaining 38 (28.6%) patients were distributed as follows: IgG + IgM + IgA in 1 patient, IgG + IgM in 8 patients, IgG alone in 24 patients and IgM alone in 5 patients. The clinical review of these patients indicated no current disease in 21 (15.8%), scanty evidence of brucellosis in 8 (6.0%) and suggestive or sufficient evidence in 9 (6.8%). Thus, ELISA is the test of choice to resort to in the case of clinical suspicion of brucellosis, even when the Coombs test shows negative findings.</p></div>","PeriodicalId":101161,"journal":{"name":"Serodiagnosis and Immunotherapy in Infectious Disease","volume":"8 3","pages":"Pages 169-172"},"PeriodicalIF":0.0,"publicationDate":"1997-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0888-0786(96)01073-6","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74145235","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 11
Comparison of a toxin neutralization assay and ELISA for determination of pertussis toxin antibodies 毒素中和法与ELISA法测定百日咳毒素抗体的比较
Serodiagnosis and Immunotherapy in Infectious Disease Pub Date : 1997-01-01 DOI: 10.1016/S0888-0786(96)01072-4
Jerker Isacson , Birger Trollfors , Teresa Lagergrd , John Taranger
{"title":"Comparison of a toxin neutralization assay and ELISA for determination of pertussis toxin antibodies","authors":"Jerker Isacson ,&nbsp;Birger Trollfors ,&nbsp;Teresa Lagergrd ,&nbsp;John Taranger","doi":"10.1016/S0888-0786(96)01072-4","DOIUrl":"10.1016/S0888-0786(96)01072-4","url":null,"abstract":"<div><p>Sera from 192 children participating in studies of a pertussis toxoid vaccine were analyzed by enzyme-linked immunosorbent assay (ELISA) for pertussis toxin IgG antibodies and by the Chinese hamster ovary cell assay for pertussis toxin neutralizing antibodies. A significant linear correlation was found between titers obtained by ELISA and the neutralization assay (<em>r</em> = 0.84, <em>P</em> &lt; 0.0001). The study shows that these two assays give similar information for groups of sera, although an antibody titer obtained by one method could generally not be used to predict a titer for the other method with accuracy in an individual serum. We propose that ELISA alone can be used in studies of IgG antibody response to pertussis toxin after vaccination with pertussis toxoid.</p></div>","PeriodicalId":101161,"journal":{"name":"Serodiagnosis and Immunotherapy in Infectious Disease","volume":"8 3","pages":"Pages 163-167"},"PeriodicalIF":0.0,"publicationDate":"1997-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0888-0786(96)01072-4","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84666429","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Comparison of a commercial ELISA kit and a neutralization assay for assessment of humoral immunity to measles virus 商用酶联免疫吸附测定试剂盒和中和试验评估麻疹病毒体液免疫的比较
Serodiagnosis and Immunotherapy in Infectious Disease Pub Date : 1997-01-01 DOI: 10.1016/S0888-0786(96)01064-5
Maureen G. Friedman , Svetlana Romanova , Aharon Galil , Batia Sarov , Ron Dagan
{"title":"Comparison of a commercial ELISA kit and a neutralization assay for assessment of humoral immunity to measles virus","authors":"Maureen G. Friedman ,&nbsp;Svetlana Romanova ,&nbsp;Aharon Galil ,&nbsp;Batia Sarov ,&nbsp;Ron Dagan","doi":"10.1016/S0888-0786(96)01064-5","DOIUrl":"10.1016/S0888-0786(96)01064-5","url":null,"abstract":"<div><p>Efficient control of measles apparently requires reimmunization of susceptibles. The classic techniques used for estimation of measles susceptibility, neutralization and hemeagglutination inhibition, are neither convenient nor exactly comparable when carried out in different laboratories. We have compared a one-dilution commercial enzyme-linked immunosorbant assay (ELISA) to a classic neutralization test with respect to its ability to designate susceptibles as well as its ability to indicate post-reimmunization rises in measles antibody levels. A group of controls not deemed to require reimmunization was tested in parallel. The results indicate that the simple and standardized commercial assay may be able to substitute for the classic assays, which can only be carried out in specialized laboratories, when simple screening for persons with low levels of antibodies to measles or when evaluations of responses to (re)immunizations are required.</p></div>","PeriodicalId":101161,"journal":{"name":"Serodiagnosis and Immunotherapy in Infectious Disease","volume":"8 3","pages":"Pages 131-135"},"PeriodicalIF":0.0,"publicationDate":"1997-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0888-0786(96)01064-5","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77726946","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Detection of toxoplasma-specific antibody in human saliva using conventional assays 用常规方法检测人唾液中弓形虫特异性抗体
Serodiagnosis and Immunotherapy in Infectious Disease Pub Date : 1997-01-01 DOI: 10.1016/S0888-0786(96)01079-7
J. Dave, A. Johnson, N. Andrews, J. Harford, A. Balfour, D. Tompkins
{"title":"Detection of toxoplasma-specific antibody in human saliva using conventional assays","authors":"J. Dave,&nbsp;A. Johnson,&nbsp;N. Andrews,&nbsp;J. Harford,&nbsp;A. Balfour,&nbsp;D. Tompkins","doi":"10.1016/S0888-0786(96)01079-7","DOIUrl":"10.1016/S0888-0786(96)01079-7","url":null,"abstract":"","PeriodicalId":101161,"journal":{"name":"Serodiagnosis and Immunotherapy in Infectious Disease","volume":"8 3","pages":"Pages 195-199"},"PeriodicalIF":0.0,"publicationDate":"1997-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0888-0786(96)01079-7","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75684607","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Modified ELISA for hydatid serodiagnosis: the potential of periodate treatment and phosphorylcholine inhibition 改良ELISA用于包虫病的血清诊断:高碘酸盐治疗和磷胆碱抑制的潜力
Serodiagnosis and Immunotherapy in Infectious Disease Pub Date : 1997-01-01 DOI: 10.1016/S0888-0786(96)01069-4
Silvia Sterla , Inger Ljungström , Alberto Nieto
{"title":"Modified ELISA for hydatid serodiagnosis: the potential of periodate treatment and phosphorylcholine inhibition","authors":"Silvia Sterla ,&nbsp;Inger Ljungström ,&nbsp;Alberto Nieto","doi":"10.1016/S0888-0786(96)01069-4","DOIUrl":"10.1016/S0888-0786(96)01069-4","url":null,"abstract":"<div><p>The effects of destruction of carbohydrate moieties of <em>Echinococcus granulosus</em> antigen by sodium periodate treatment, and/or blocking phosphorylcholine specific antibodies by the addition of free reagent, were investigated to improve sensitivity and specificity of enzyme-linked immunoabsorbent assay (ELISA) for diagnosis of hydatid disease. Sera were collected, in Uruguay and Sweden, from patients with confirmed hydatidosis, non-hydatid tapeworm infections, other disorders, and healthy donors. ELISA performed with sodium periodate or free phosphorylcholine increased sensitivity, but decreased specificity. Western blot analysis showed reduced recognition of the 38 kDa antigen following both treatments, and of the 15.5 kDa antigen after periodate treatment. Addition of free phosphorylcholine enhanced the recognition of two antigens, 26 and 50 kDa, which may represent new cross-reacting epitopes.</p></div>","PeriodicalId":101161,"journal":{"name":"Serodiagnosis and Immunotherapy in Infectious Disease","volume":"8 3","pages":"Pages 145-148"},"PeriodicalIF":0.0,"publicationDate":"1997-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0888-0786(96)01069-4","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87093175","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 14
The use of recombinant Escherichia coli LamB protein to study the human antibody response to an individual meningococcal PorA outer membrane protein epitope 利用重组大肠杆菌LamB蛋白研究人对单个脑膜炎球菌PorA外膜蛋白表位的抗体反应
Serodiagnosis and Immunotherapy in Infectious Disease Pub Date : 1997-01-01 DOI: 10.1016/S0888-0786(96)01065-7
M.E. Taylor , J. McCarvil , I.M. Feavers , D.M. Jones , A.J. Fox
{"title":"The use of recombinant Escherichia coli LamB protein to study the human antibody response to an individual meningococcal PorA outer membrane protein epitope","authors":"M.E. Taylor ,&nbsp;J. McCarvil ,&nbsp;I.M. Feavers ,&nbsp;D.M. Jones ,&nbsp;A.J. Fox","doi":"10.1016/S0888-0786(96)01065-7","DOIUrl":"10.1016/S0888-0786(96)01065-7","url":null,"abstract":"<div><p>Recombinant <em>Escherichia coli</em> LamB proteins containing meningococcal PorA epitopes were used for the analysis of the human antibody response to specific PorA epitopes. Sera from meningococcal cases, carriers and controls were examined by an ELISA-inhibition assay. Antibody to the serosubtype P1.16 epitope was detected with similar frequency regardless of whether recombinant <em>E. coli</em> LamB protein containing P1.16 or SDS-PAGE purified meningococcal class 1 protein (serosubtype P1.16) was used as the antigen.</p></div>","PeriodicalId":101161,"journal":{"name":"Serodiagnosis and Immunotherapy in Infectious Disease","volume":"8 3","pages":"Pages 137-143"},"PeriodicalIF":0.0,"publicationDate":"1997-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0888-0786(96)01065-7","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90389538","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The immune response to a meningococcal 200 kDa surface exposed protein following carriage and disease 携带和患病后对脑膜炎球菌200 kDa表面暴露蛋白的免疫反应
Serodiagnosis and Immunotherapy in Infectious Disease Pub Date : 1997-01-01 DOI: 10.1016/S0888-0786(96)01075-X
R. Borrow, A.J. Fox, D.M. Jones
{"title":"The immune response to a meningococcal 200 kDa surface exposed protein following carriage and disease","authors":"R. Borrow,&nbsp;A.J. Fox,&nbsp;D.M. Jones","doi":"10.1016/S0888-0786(96)01075-X","DOIUrl":"10.1016/S0888-0786(96)01075-X","url":null,"abstract":"<div><p>Considerable efforts are being made in the search for suitable candidates for an effective serogroup B meningococcal vaccine, but with limited success. We have identified a novel, high molecular weight antigen of approximately 200 kDa. The antigen was expressed during invasive disease as 100% of convalescent case sera contained antibody compared with approximately 50% of carriers. Many clinical isolates did not appear to express the 200 kDa antigen, but corresponding sera contained antibody, indicating in vivo expression. Antibody to this antigen cross-reacted with meningococci of diverse phenotypes. Further investigation of this antigen is required to determine its potential as a future vaccine component.</p></div>","PeriodicalId":101161,"journal":{"name":"Serodiagnosis and Immunotherapy in Infectious Disease","volume":"8 3","pages":"Pages 179-184"},"PeriodicalIF":0.0,"publicationDate":"1997-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0888-0786(96)01075-X","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84614942","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
First documented case of human immunodeficiency virus type 2 infection in Turkey 土耳其首例人类免疫缺陷病毒2型感染病例
Serodiagnosis and Immunotherapy in Infectious Disease Pub Date : 1996-05-01 DOI: 10.1016/S0888-0786(96)80012-6
G. Yilmaz , H. Akalin , N. Işik , A.H. Assaf , O. Töre , S. Badur
{"title":"First documented case of human immunodeficiency virus type 2 infection in Turkey","authors":"G. Yilmaz ,&nbsp;H. Akalin ,&nbsp;N. Işik ,&nbsp;A.H. Assaf ,&nbsp;O. Töre ,&nbsp;S. Badur","doi":"10.1016/S0888-0786(96)80012-6","DOIUrl":"10.1016/S0888-0786(96)80012-6","url":null,"abstract":"","PeriodicalId":101161,"journal":{"name":"Serodiagnosis and Immunotherapy in Infectious Disease","volume":"8 2","pages":"Page 125"},"PeriodicalIF":0.0,"publicationDate":"1996-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0888-0786(96)80012-6","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87856124","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
IPAzyme Chlamydia and microimmunofluorescence tests for detecting antibodies against Chlamydia trachomatis in women undergoing laparoscopy IPAzyme衣原体和微免疫荧光试验检测腹腔镜妇女沙眼衣原体抗体
Serodiagnosis and Immunotherapy in Infectious Disease Pub Date : 1996-05-01 DOI: 10.1016/S0888-0786(96)80001-1
R. Zbinden , G. Bon , I. Heinzer , M.F. Paccaud , G. Schär , W. Stoll
{"title":"IPAzyme Chlamydia and microimmunofluorescence tests for detecting antibodies against Chlamydia trachomatis in women undergoing laparoscopy","authors":"R. Zbinden ,&nbsp;G. Bon ,&nbsp;I. Heinzer ,&nbsp;M.F. Paccaud ,&nbsp;G. Schär ,&nbsp;W. Stoll","doi":"10.1016/S0888-0786(96)80001-1","DOIUrl":"10.1016/S0888-0786(96)80001-1","url":null,"abstract":"<div><p>Superficial <em>Chlamydia trachomatis</em> infections are diagnosed by antigen detection whereas serological investigations are mainly performed to detect deep-seated infections. In this study the genus-specific IPAzyme and two species-specific microimmunofluorescence (MIF) tests were compared for detecting antibodies against <em>C. trachomatis</em> in women undergoing laparoscopy for diagnostic purposes or for ligation of the fallopian tubes. Microbiological findings were similar in both groups. <em>C. trachomatis</em> was detected in 4 of 38 women with ligation and in 6 of 61 women with diagnostic laparoscopy. Serum IgG antibody titres by IPAzyme were clearly positive in 24 out of 61 of the diagnostic group and in 12 out of 38 of the ligation group. However, 14 (39%) of the 36 IPAzyme-positive results were caused by antibodies against <em>Chlamydia pneumoniae</em> and/or <em>Chlamydia psittaci</em>, only 4 (11%) were caused by anti-<em>C. trachomatis</em> IgG and 8 (22%) were caused by both antibodies as tested by a conventional MIF; in 10 all MIF titres were lower than 1:32. A commercial MIF still containing too much genus-specific lipopolysaccharides was more sensitive, but also more crossreactive than the conventional MIF. IPAzyme IgA were only found in association with positive IPAzyme IgG results. We conclude that in case of presumed deep-seated <em>C. trachomatis</em> infection only sensitive species-specific assays for detecting <em>C. trachomatis</em> antibodies are helpful. IPAzyme and other genus-specific assays cannot be recommended to detect antibodies to <em>C. trachomatis</em> in the serum, because positive results are caused mainly by antibodies against respiratory chlamydiae.</p></div>","PeriodicalId":101161,"journal":{"name":"Serodiagnosis and Immunotherapy in Infectious Disease","volume":"8 2","pages":"Pages 67-71"},"PeriodicalIF":0.0,"publicationDate":"1996-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0888-0786(96)80001-1","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73653710","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative evaluation of commercial methods for the detection of parvovirus B19-specific immunoglobulin M 细小病毒b19特异性免疫球蛋白M检测方法的比较评价
Serodiagnosis and Immunotherapy in Infectious Disease Pub Date : 1996-05-01 DOI: 10.1016/S0888-0786(96)80010-2
Fernando de Ory, María Eulalia Guisasola, Alicia Téllez, Carlos Jorge Domingo
{"title":"Comparative evaluation of commercial methods for the detection of parvovirus B19-specific immunoglobulin M","authors":"Fernando de Ory,&nbsp;María Eulalia Guisasola,&nbsp;Alicia Téllez,&nbsp;Carlos Jorge Domingo","doi":"10.1016/S0888-0786(96)80010-2","DOIUrl":"10.1016/S0888-0786(96)80010-2","url":null,"abstract":"<div><p>The serological diagnosis of parvovirus B19 (PVB19) was performed by radioimmunoassay or enzyme-linked immunosorbent assay (ELISA), using plasma-derived antigen, in view of the difficulties in obtaining the virus. Since the development of recombinant proteins, a number of commercial kits for detecting both specific immunoglobulin G (IgG) and IgM have become available. We evaluated seven methods, including indirect- and <em>μ</em>-chain-capture ELISA, indirect immunofluorescence and Western blot, in an effort to identify PVB19 IgM. In acute samples of erythema infectiosum, the sensitivity ranged from 37% to 91%; in all samples from primary PVB19 infections, including acute and convalescent samples of erythema infectiosum, and from other primary infections in adults, the sensitivity varied from 31% to 79%. When samples from rubella, measles, infectious mononucleosis and healthy pregnant women were tested, specificity ranged from 67% to 100%. Not all the kits evaluated can be used to diagnose PVB19 infections in view of the limitations of some kits with respect to sensitivity and, more importantly, specificity.</p></div>","PeriodicalId":101161,"journal":{"name":"Serodiagnosis and Immunotherapy in Infectious Disease","volume":"8 2","pages":"Pages 117-120"},"PeriodicalIF":0.0,"publicationDate":"1996-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0888-0786(96)80010-2","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81227770","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信